EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Cancer‐induced cardiac atrophy adversely affects myocardial redox state and mitochondrial oxidative characteristics

David E Lee, Jacob L Brown, Megan E Rosa-Caldwell, Richard A Perry, Lemuel A Brown, Wesley S Haynie, Tyrone A Washington, Michael P Wiggs, Narasimhan Rajaram, Nicholas P Greene

JCSM Rapid Communications · 2021

DOI: 10.1002/rco2.18 ↗

Kurz gefasst

Fachartikel in der Zeitschrift JCSM Rapid Communications, 2021. Verfasst von David E Lee und 9 weiteren Autor:innen. Beteiligte Einrichtung: Cachexia Research Laboratory, Department of Health, Human Performance and Recreation, University of Arkansas, Fayetteville, Arkansas, USA. Die Arbeit wurde bisher 24-mal zitiert (Crossref) und nennt 85 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIAMS NIH HHS, National Institutes of Health, Arkansas Biosciences Institute.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Cachexia presents in 80% of advanced cancer patients; however, cardiac atrophy in cachectic patients receives little attention. This cardiomyopathy contributes to increased occurrence of adverse cardiac events compared with age‐matched population norms. Research on cardiac atrophy has focused on remodelling; however, alterations in metabolic properties may be a primary contributor. The purpose of the study is to determine how cancer‐induced cardiac atrophy alters mitochondrial turnover, mitochondrial mRNA translation machinery, and in vitro oxidative characteristics.

Methods

Lewis lung carcinoma (LLC) tumours were implanted in C57BL6/J mice and grown for 28 days to induce cardiac atrophy. Endogenous metabolic species and markers of mitochondrial function were assessed. H9c2 cardiomyocytes were cultured in LLC‐conditioned media with (out) the antioxidant MitoTempo. Cells were analysed for reactive oxygen species (ROS), oxidative capacity, and hypoxic resistance.

Results

LLC heart weights were ~10% lower than controls. LLC hearts demonstrated ~15% lower optical redox ratio [flavin adenine dinucleotide (FAD)/FAD + nicotinamide adenine dinucleotide hydrogen (NADH)] compared with phosphate‐buffered saline controls. When compared with phosphate‐buffered saline, LLC hearts showed ~50% greater Cytochrome‐C oxidase subunit 4 (COX‐IV) and Voltage‐dependent anion channel (VDAC), attributed to ~50% lower mitophagy markers. mt‐mRNA translation machinery was elevated similarly to markers of mitochondrial content. Mitochondrial DNA‐encoded Cytb was ~30% lower in LLC hearts. ROS scavengers GPx‐3 and GPx‐7 were ~50% lower in LLC hearts. Treatment of cardiomyocytes with LLC‐conditioned media resulted in higher ROS (25%), lower oxygen consumption rates (10% at basal and 75% at maximal), and greater susceptibility to hypoxia (~25%), which was reversed by MitoTempo.

Conclusions

These results substantiate metabolic cardiotoxic effects attributable to tumour‐associated factors and provide insight into interactions between mitochondrial mRNA translation, ROS mitigation, oxidative capacity, and hypoxia resistance.

Schlagwörter

Stichwörter der Autor:innen

Cardiac cachexiacardiac wastingcardio-oncologymitochondrial translationoptical redox imaging

Autor:innen und Institutionen

  • Cachexia Research Laboratory, Department of Health, Human Performance and Recreation, University of Arkansas, Fayetteville, Arkansas, USA.
  • Laboratory for Functional Optical Imaging and Spectroscopy, Department of Biomedical Engineering, University of Arkansas, Fayetteville, Arkansas, USA.
  • Exercise Muscle Biology Laboratory, Department of Health, Human Performance and Recreation, University of Arkansas, Fayetteville, Arkansas, USA.
  • Department of Health and Kinesiology, University of Texas at Tyler, Tyler, Texas, USA.

Förderung

  • NIAMS NIH HHS
  • National Institutes of Health
  • Arkansas Biosciences Institute

Zitieren

APA

Lee, D. E., Brown, J. L., Rosa-Caldwell, M. E., Perry, R. A., Brown, L. A., Haynie, W. S., Washington, T. A., Wiggs, M. P., Rajaram, N., & Greene, N. P. (2021). Cancer‐induced cardiac atrophy adversely affects myocardial redox state and mitochondrial oxidative characteristics. JCSM Rapid Communications. https://doi.org/10.1002/rco2.18

Vancouver

Lee DE, Brown JL, Rosa-Caldwell ME, Perry RA, Brown LA, Haynie WS, et al. Cancer‐induced cardiac atrophy adversely affects myocardial redox state and mitochondrial oxidative characteristics. JCSM Rapid Communications. 2021. doi:10.1002/rco2.18

BibTeX
@article{Lee2021,
  author = {Lee, David E and Brown, Jacob L and Rosa-Caldwell, Megan E and Perry, Richard A and Brown, Lemuel A and Haynie, Wesley S and Washington, Tyrone A and Wiggs, Michael P and Rajaram, Narasimhan and Greene, Nicholas P},
  title = {Cancer‐induced cardiac atrophy adversely affects myocardial redox state and mitochondrial oxidative characteristics},
  journal = {JCSM Rapid Communications},
  year = {2021},
  doi = {10.1002/rco2.18}
}
Kostenlos starten →